Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells

Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA 1 Author for correspondence: Martin Muggeridge. Fax +1 318 675 5764. e-mail mmugge{at}lsumc.edu The mechanisms by which herpes simplex viruses (HSV) mediate fus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of general virology 2000-08, Vol.81 (8), p.2017-2027
1. Verfasser: Muggeridge, Martin I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2027
container_issue 8
container_start_page 2017
container_title Journal of general virology
container_volume 81
creator Muggeridge, Martin I
description Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA 1 Author for correspondence: Martin Muggeridge. Fax +1 318 675 5764. e-mail mmugge{at}lsumc.edu The mechanisms by which herpes simplex viruses (HSV) mediate fusion between their envelope and the plasma membrane during entry into cells, and between the plasma membranes of adjacent infected and uninfected cells to form multinucleated giant cells, are poorly understood. Four viral glycoproteins (gB, gD, gH and gL) are required for virus–cell fusion, whereas these plus several others are required for cell–cell fusion (syncytium formation). A better understanding would be aided by the availability of a model system, whereby fusion could be induced with a minimal set of proteins, in the absence of infection. A suitable system has now been developed for HSV-2, using transfected COS7, 293 or HEp-2 cells. Insofar as the minimal set of HSV-2 proteins required to cause cell–cell fusion in this system is gB, gD, gH and gL, it would appear to resemble virus–cell fusion rather than syncytium formation. However, the ability of a mutation in gB to enhance the fusion of both transfected cells and infected cells, while having no effect on virus–cell fusion, points to the opposite conclusion. The differential effects of a panel of anti-HSV antibodies, and of the fusion-inhibitor cyclosporin A, confirm that the fusion of transfected cells shares some properties with virus–cell fusion and others with syncytium formation. It may therefore prove useful for determining how these processes differ, and for testing the hypothesis that some viral proteins prevent membrane fusion until the appropriate point in the virus life-cycle, with other proteins then overcoming this block.
doi_str_mv 10.1099/0022-1317-81-8-2017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71253271</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17550988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-9f7d811c76d0756398feeae3f3f61ac6fd81eee519658ddd0b163b552e34df7a3</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS0EokvLJ0BCPiEOBDxxHDtHutAWaSUu9Gw58ThrlD-LndAu4sNjayvKjYPtkf17z6M3hLwC9h5Y03xgrCwL4CALBYUqSgbyCdlAVYtUN81TsvlLnJEXMX5nDKpKyOfkLOkZYxVsyO_t3gTTLRj8L7P4eaKzox0OQ5E36taY70a03ixoaXukewwHjDT68TDgPf3pwxppSfvh2M2HMC_op0j7y3e0_5TWDTWTpf2O-okuwUzRYZeNsnu8IM-cGSK-fDjPye3V52_bm2L39frL9uOu6CpZL0XjpFUAnawtk6LmjXKIBrnjrgbT1S69IqKAphbKWstaqHkrRIm8sk4afk7enHxTfz9WjIsefcwdmAnnNWoJpeClhP-CIIVgjVIJ5CewC3OMAZ0-BD-acNTAdJ6OztnrnL1WoJXO00mq1w_2a5si_UdzGkcC3p6Ave_3dz6g7nEaffqk9bNOUT96_QG4cplk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17550988</pqid></control><display><type>article</type><title>Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells</title><source>MEDLINE</source><source>Microbiology Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Muggeridge, Martin I</creator><creatorcontrib>Muggeridge, Martin I</creatorcontrib><description>Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA 1 Author for correspondence: Martin Muggeridge. Fax +1 318 675 5764. e-mail mmugge{at}lsumc.edu The mechanisms by which herpes simplex viruses (HSV) mediate fusion between their envelope and the plasma membrane during entry into cells, and between the plasma membranes of adjacent infected and uninfected cells to form multinucleated giant cells, are poorly understood. Four viral glycoproteins (gB, gD, gH and gL) are required for virus–cell fusion, whereas these plus several others are required for cell–cell fusion (syncytium formation). A better understanding would be aided by the availability of a model system, whereby fusion could be induced with a minimal set of proteins, in the absence of infection. A suitable system has now been developed for HSV-2, using transfected COS7, 293 or HEp-2 cells. Insofar as the minimal set of HSV-2 proteins required to cause cell–cell fusion in this system is gB, gD, gH and gL, it would appear to resemble virus–cell fusion rather than syncytium formation. However, the ability of a mutation in gB to enhance the fusion of both transfected cells and infected cells, while having no effect on virus–cell fusion, points to the opposite conclusion. The differential effects of a panel of anti-HSV antibodies, and of the fusion-inhibitor cyclosporin A, confirm that the fusion of transfected cells shares some properties with virus–cell fusion and others with syncytium formation. It may therefore prove useful for determining how these processes differ, and for testing the hypothesis that some viral proteins prevent membrane fusion until the appropriate point in the virus life-cycle, with other proteins then overcoming this block.</description><identifier>ISSN: 0022-1317</identifier><identifier>EISSN: 1465-2099</identifier><identifier>DOI: 10.1099/0022-1317-81-8-2017</identifier><identifier>PMID: 10900041</identifier><language>eng</language><publisher>England: Soc General Microbiol</publisher><subject>Animals ; Antibodies, Monoclonal - immunology ; COS Cells ; Cyclosporine - pharmacology ; Herpes simplex virus 2 ; Herpesvirus 2, Human - physiology ; Membrane Fusion ; Transfection ; Viral Envelope Proteins - physiology</subject><ispartof>Journal of general virology, 2000-08, Vol.81 (8), p.2017-2027</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-9f7d811c76d0756398feeae3f3f61ac6fd81eee519658ddd0b163b552e34df7a3</citedby><cites>FETCH-LOGICAL-c476t-9f7d811c76d0756398feeae3f3f61ac6fd81eee519658ddd0b163b552e34df7a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3745,3746,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10900041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muggeridge, Martin I</creatorcontrib><title>Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells</title><title>Journal of general virology</title><addtitle>J Gen Virol</addtitle><description>Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA 1 Author for correspondence: Martin Muggeridge. Fax +1 318 675 5764. e-mail mmugge{at}lsumc.edu The mechanisms by which herpes simplex viruses (HSV) mediate fusion between their envelope and the plasma membrane during entry into cells, and between the plasma membranes of adjacent infected and uninfected cells to form multinucleated giant cells, are poorly understood. Four viral glycoproteins (gB, gD, gH and gL) are required for virus–cell fusion, whereas these plus several others are required for cell–cell fusion (syncytium formation). A better understanding would be aided by the availability of a model system, whereby fusion could be induced with a minimal set of proteins, in the absence of infection. A suitable system has now been developed for HSV-2, using transfected COS7, 293 or HEp-2 cells. Insofar as the minimal set of HSV-2 proteins required to cause cell–cell fusion in this system is gB, gD, gH and gL, it would appear to resemble virus–cell fusion rather than syncytium formation. However, the ability of a mutation in gB to enhance the fusion of both transfected cells and infected cells, while having no effect on virus–cell fusion, points to the opposite conclusion. The differential effects of a panel of anti-HSV antibodies, and of the fusion-inhibitor cyclosporin A, confirm that the fusion of transfected cells shares some properties with virus–cell fusion and others with syncytium formation. It may therefore prove useful for determining how these processes differ, and for testing the hypothesis that some viral proteins prevent membrane fusion until the appropriate point in the virus life-cycle, with other proteins then overcoming this block.</description><subject>Animals</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>COS Cells</subject><subject>Cyclosporine - pharmacology</subject><subject>Herpes simplex virus 2</subject><subject>Herpesvirus 2, Human - physiology</subject><subject>Membrane Fusion</subject><subject>Transfection</subject><subject>Viral Envelope Proteins - physiology</subject><issn>0022-1317</issn><issn>1465-2099</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9v1DAQxS0EokvLJ0BCPiEOBDxxHDtHutAWaSUu9Gw58ThrlD-LndAu4sNjayvKjYPtkf17z6M3hLwC9h5Y03xgrCwL4CALBYUqSgbyCdlAVYtUN81TsvlLnJEXMX5nDKpKyOfkLOkZYxVsyO_t3gTTLRj8L7P4eaKzox0OQ5E36taY70a03ixoaXukewwHjDT68TDgPf3pwxppSfvh2M2HMC_op0j7y3e0_5TWDTWTpf2O-okuwUzRYZeNsnu8IM-cGSK-fDjPye3V52_bm2L39frL9uOu6CpZL0XjpFUAnawtk6LmjXKIBrnjrgbT1S69IqKAphbKWstaqHkrRIm8sk4afk7enHxTfz9WjIsefcwdmAnnNWoJpeClhP-CIIVgjVIJ5CewC3OMAZ0-BD-acNTAdJ6OztnrnL1WoJXO00mq1w_2a5si_UdzGkcC3p6Ave_3dz6g7nEaffqk9bNOUT96_QG4cplk</recordid><startdate>20000801</startdate><enddate>20000801</enddate><creator>Muggeridge, Martin I</creator><general>Soc General Microbiol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20000801</creationdate><title>Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells</title><author>Muggeridge, Martin I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-9f7d811c76d0756398feeae3f3f61ac6fd81eee519658ddd0b163b552e34df7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>COS Cells</topic><topic>Cyclosporine - pharmacology</topic><topic>Herpes simplex virus 2</topic><topic>Herpesvirus 2, Human - physiology</topic><topic>Membrane Fusion</topic><topic>Transfection</topic><topic>Viral Envelope Proteins - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muggeridge, Martin I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of general virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muggeridge, Martin I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells</atitle><jtitle>Journal of general virology</jtitle><addtitle>J Gen Virol</addtitle><date>2000-08-01</date><risdate>2000</risdate><volume>81</volume><issue>8</issue><spage>2017</spage><epage>2027</epage><pages>2017-2027</pages><issn>0022-1317</issn><eissn>1465-2099</eissn><abstract>Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA 1 Author for correspondence: Martin Muggeridge. Fax +1 318 675 5764. e-mail mmugge{at}lsumc.edu The mechanisms by which herpes simplex viruses (HSV) mediate fusion between their envelope and the plasma membrane during entry into cells, and between the plasma membranes of adjacent infected and uninfected cells to form multinucleated giant cells, are poorly understood. Four viral glycoproteins (gB, gD, gH and gL) are required for virus–cell fusion, whereas these plus several others are required for cell–cell fusion (syncytium formation). A better understanding would be aided by the availability of a model system, whereby fusion could be induced with a minimal set of proteins, in the absence of infection. A suitable system has now been developed for HSV-2, using transfected COS7, 293 or HEp-2 cells. Insofar as the minimal set of HSV-2 proteins required to cause cell–cell fusion in this system is gB, gD, gH and gL, it would appear to resemble virus–cell fusion rather than syncytium formation. However, the ability of a mutation in gB to enhance the fusion of both transfected cells and infected cells, while having no effect on virus–cell fusion, points to the opposite conclusion. The differential effects of a panel of anti-HSV antibodies, and of the fusion-inhibitor cyclosporin A, confirm that the fusion of transfected cells shares some properties with virus–cell fusion and others with syncytium formation. It may therefore prove useful for determining how these processes differ, and for testing the hypothesis that some viral proteins prevent membrane fusion until the appropriate point in the virus life-cycle, with other proteins then overcoming this block.</abstract><cop>England</cop><pub>Soc General Microbiol</pub><pmid>10900041</pmid><doi>10.1099/0022-1317-81-8-2017</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1317
ispartof Journal of general virology, 2000-08, Vol.81 (8), p.2017-2027
issn 0022-1317
1465-2099
language eng
recordid cdi_proquest_miscellaneous_71253271
source MEDLINE; Microbiology Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Antibodies, Monoclonal - immunology
COS Cells
Cyclosporine - pharmacology
Herpes simplex virus 2
Herpesvirus 2, Human - physiology
Membrane Fusion
Transfection
Viral Envelope Proteins - physiology
title Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T16%3A06%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20cell-cell%20fusion%20mediated%20by%20herpes%20simplex%20virus%202%20glycoproteins%20gB,%20gD,%20gH%20and%20gL%20in%20transfected%20cells&rft.jtitle=Journal%20of%20general%20virology&rft.au=Muggeridge,%20Martin%20I&rft.date=2000-08-01&rft.volume=81&rft.issue=8&rft.spage=2017&rft.epage=2027&rft.pages=2017-2027&rft.issn=0022-1317&rft.eissn=1465-2099&rft_id=info:doi/10.1099/0022-1317-81-8-2017&rft_dat=%3Cproquest_cross%3E17550988%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17550988&rft_id=info:pmid/10900041&rfr_iscdi=true